Research and development in the pharmaceutical industry will never stop. The recent outbreak of COVID19 pandemic has brought the burden on the healthcare industry to analyse the symptoms of the disease to manufacture a drug. 

It requires a lot of efforts from grouping to collecting samples, evaluating samples, and producing an effective with minimal side effects. Of course, it is a time-consuming and tough job. Still, artificial intelligence (AI) has automated several tasks that researchers and drug manufacturers were relying on human intelligence to perform traditionally. 

The use of AI has gone up in the entire health industry, and the pharmaceutical industry is going through the evolvement too. Pharmaceutical businesses thrive on innovation, and hence companies are investing in AI. Here is how the pharmaceutical industry can help save millions of lives when collaborates with AI.

It tests components to finds new treatments.

A successful clinical trial is a must before the launch of a new drug. Before AI, the approval rate was not impressive. Further, it would take a lot of time, putting the lives of millions of people at risk. Advanced AI technology has made it easier to manufacture a drug quickly. After collecting the samples, AI classifies cells based on the different experimental compounds and then identifies compounds that show similar results. Then the data is presented to researchers to get an insight into the effects of trials. 

Of course, drug discovery takes a lot of time as you have to test each compound against the collected samples. Then the result you get requires more in-depth analysis to ensure that the drug is suitable to all patients, including those with medical conditions. AI uses digital images to perform the entire function, and hence it takes less time. Computers can quickly reveal new data sets compared to traditional methods of analysing the data collected from trials. Further, it is cheaper than the conventional way of collecting data and conducting research.

It gives insight into most complex diseases.

Automated algorithms can also help offer solutions by running a more in-depth analysis of samples for complex diseases like Alzheimer’s and Parkinson’s. It is helping to manufacture the most effective drug because it can identify various genes responsible for causing illnesses that were very hard to test through traditional methods. If possible, it would take a lot of time. 

AI can also analyse findings with a patient’s clinical history and then give an insight to researchers and medical experts. It can understand the pattern of how the disease is affecting people with a different medical condition.

Besides, AI can also remotely monitor the improvement in patients of complex diseases like Parkinson’s. It can take the real-time record of movements and symptoms. It helps manufacture a drug by taking into account even those symptoms that people did not show during the trial. 

It improves drug adherence.

Drug adherence is the significant challenges that pharmaceutical companies face. If people do not abide by trial rules, the manufacturing of a drug will not be possible. It is crucial to get as accurate data as possible to discover a drug that cures a disease effectively and hence people have to stick to the dosage recommended during the trial. To deal with this complication, pharmaceutical research labs are using AI. 

AI-based tools can track people if they swallowed the pill or not by videotaping them. Traditional methods of conducting trials were not effective as there was no evidence to see if people stuck to the drug dosage, but now AI can give a real-time scenario. There is no denying that it improves drug adherence to get real and accurate data to research a drug. 

It helps with better analysis of clinical data.

AI can quickly extract medical data and analyses structured and unstructured data in real-time to establish the link between patterns and narrow down the trial based on the most influential factors. Also, AI is powerful to collect real symptoms of patients with the help of facial recognition features. 

Since it can help you compare between clinical history and real-time symptoms, you can better understand how a particular disease affects people and what drug can be produced for treatment.  

It picks suitable people for trials.

Picking suitable candidates is another challenge that pharmaceutical companies face. Thanks to AI that can easily manage to prepare the list of participants. There must be a benchmark that researchers will use to decide if the participants are eligible for the clinical trial. 

Here comes the role of AI. It analyses structured and unstructured data and then separates critical elements to creating a profile that researchers use to find suitable candidates. Creating an appropriate pattern for trials does not consume a lot of time as AI performs it without further ado. 

AI has improved the progress of drug manufacturing. There are several companies continually putting efforts to give the best AI-powered tools to pharmaceutical companies to understand the symptoms of diseases to produce an active drug. 

AI has proved to be the most effective source to discover drugs faster, and hence laboratories are investing in this technology. Some of the pharmaceutical companies are taking out very bad credit loans with no guarantor. Investing in AI can be lucrative for your company. However, if you need money to fund it, make sure that you borrow money from a reputed direct lender like Target Loans.